Trials / Active Not Recruiting
Active Not RecruitingNCT07059832
Application of 68Ga-NODAGA-SNA006 Positron Emission Tomography/Computed Tomography (PET/CT) in Tumors
Application of 68Ga-NODAGA-SNA006 in Patients With Solid Tumor or Lymphoma
- Status
- Active Not Recruiting
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- First Hospital of China Medical University · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
This is an open-label positron emission tomography/computed tomography (PET/CT) study to investigate the safety and clinical predictive value of 68Ga-NODAGA-SNA006 in subjects with solid tumor or lymphoma.
Detailed description
The aim of this study was to explore the safety and clinical predictive value of 68Ga-NODAGA-SNA006 in patients with solid tumors or lymphoma.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 68Ga-NODAGA-SNA006 | 68Ga-NODAGA-SNA006 PET/CT: after intravenous injection of 0.05 mCi/kg body weight of quality-controlled 68Ga-NODAGA-SNA006, an integrated PET/CT scanner (Biograph mCT; Siemens, Germany) will be applied. |
Timeline
- Start date
- 2024-04-01
- Primary completion
- 2028-01-01
- Completion
- 2028-04-01
- First posted
- 2025-07-11
- Last updated
- 2025-07-11
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07059832. Inclusion in this directory is not an endorsement.